{"id":92,"date":"2019-09-22T17:49:44","date_gmt":"2019-09-22T17:49:44","guid":{"rendered":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/3-3-antimicrobial-administration-considerations\/"},"modified":"2025-01-16T22:29:16","modified_gmt":"2025-01-16T22:29:16","slug":"3-3-antimicrobial-administration-considerations","status":"publish","type":"chapter","link":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/3-3-antimicrobial-administration-considerations\/","title":{"raw":"3.3 Antimicrobial Administration Considerations","rendered":"3.3 Antimicrobial Administration Considerations"},"content":{"raw":"The administration of antimicrobial drug therapy involves special considerations to ensure that the therapeutic drug effect is achieved while also maintaining patient safety and minimizing complications.\n\nLet's consider variables that impact antimicrobial administration, such as half-life, life span considerations, liver and kidney function, dose dependency\/time dependency, route, and drug interactions.\n<h2>Half-Life<\/h2>\n<span style=\"text-align: initial;font-size: 1em\">Many antimicrobial medications are administered to ensure a certain therapeutic level of medication remains in the bloodstream, which may require interval or repeated dosing throughout the day. Recall from Chapter 1 that <\/span>half-life is the<span style=\"text-align: initial;font-size: 1em\"> rate at which 50% of a drug is eliminated from the plasma. Half-life can vary significantly among antimicrobial drugs. Some antibiotics, such as penicillin, have a short half-life of only a few hours and must be administered multiple times a day, whereas other antibiotics, such as levofloxacin, have long half-lives and can be administered as a single dose every 24 hours. <\/span>\n\n<span style=\"text-align: initial;font-size: 1em\">Although a longer half-life can be considered an advantage for a prescribed antibiotic when it comes to convenient dosing intervals, medications with longer half-lives that cause side effects will also exert these side effects over a longer period of time.\u00a0<\/span>\n<h2>Life Span Considerations<\/h2>\nMany antibiotic dosages are calculated based on the client's age and weight. Age and weight are especially important when calculating pediatric dosages, resulting in common medication errors when these calculations are inaccurate. The size and development of the internal organs in infants and children also impact how the body absorbs, distributes, metabolizes, and excretes medications.\n\nIn older adults, metabolism of antibiotics by the liver may significantly decline in the older adult. As a result, dosages should be adjusted according to the client\u2019s liver function and their anticipated metabolic rate. First-pass metabolism also decreases with aging, so older adults may have higher \u201cfree\u201d circulating drug concentrations and thus be at higher risk for side effects and toxicities.\n<h2>Liver and Kidney Function<\/h2>\nMany antimicrobial medications require tailored dosing based on the client's liver and kidney function. For more information about the effects of liver and kidney function on metabolizing and excreting medications, review <a href=\"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/1-5-metabolism\/\" target=\"_blank\" rel=\"noopener\">Chapter 1<\/a>.\n\nPeak and trough blood levels are monitored for some antibiotics to determine how a client's body is responding to an antimicrobial. Dosing is then tailored to the individual based on peak and trough levels. This is especially important for older adults or those with known liver and\/or kidney impairment. Individuals with diminished liver and kidney function are prone to developing toxic levels of medications because of their reduced ability to metabolize or clear medications from the body. For more information about peak and trough levels, review the \"<a href=\"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/1-9-efficacy-dose-response-onset-peak-and-duration\/\" target=\"_blank\" rel=\"noopener\">Efficacy, Dose-Response, Onset, Peak, and Duration<\/a>\" section in Chapter 1.<sup>[footnote]This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a>[\/footnote]<\/sup>\n<h2>Dose Dependency\/Time Dependency<\/h2>\nThe goal of antimicrobial therapy is to select an optimal dosage that will result in clinical cure, while reducing potential side effects and adverse effects. Many medications are <strong>[pb_glossary id=\"507\"]dose dependent[\/pb_glossary]<\/strong>, meaning\u00a0there is a more significant killing of the bacteria with increasing levels of the antibiotic. For example, fluroquinolones are dose-dependent medications with higher dosages of antibiotic killing more bacteria.\n\nOther medications are <strong>[pb_glossary id=\"508\"]time dependent[\/pb_glossary]<\/strong>. Time-dependent medications have optimal bacterial-killing effect at lower doses over a longer period of time. Time-dependent antimicrobials exert their effect by binding to the microorganism for an extensive length of time. Penicillin is an example of a time-dependent medication where duration of the bacteria's exposure to the medication has the greatest effect.<sup>[footnote]This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a>[\/footnote]<\/sup>\n<h2>Route<\/h2>\nWhen administering antimicrobials to clients, nurses must consider the route of drug administration. Many of us may have been prescribed oral antibiotics and have simply filled our prescription and completed the drug therapy within the comfort of our own homes. However, there are many types of infections that do not respond well to oral antimicrobial therapy and require intravenous or intramuscular injections. Clients requiring intravenous or intramuscular injections may require additional considerations regarding hospitalization, home health nursing, or travel to the hospital\/clinic for their therapy. For more information about considerations regarding routes of administration, refer to <a href=\"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/1-3-absorption\/\" target=\"_blank\" rel=\"noopener\">Chapter 1<\/a> on absorption.\n<h2>Drug Interactions<\/h2>\nInteractions between drugs may be beneficial or harmful. For example, when treating specific infections, two antibacterial drugs may be administered together to create a greater effect than the efficacy of either medication alone, referred to as <strong>[pb_glossary id=\"509\"]synergistic interaction [\/pb_glossary]<\/strong>. An example of a synergistic drug combinations is trimethoprim and sulfamethoxazole (Bactrim). Individually, these two drugs provide only bacteriostatic inhibition of bacterial growth, but combined, the drugs are bactericidal.<sup>[footnote]This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a>[\/footnote]<\/sup>\n\nIn contrast to synergistic drug interactions providing a benefit to the client, <strong>[pb_glossary id=\"510\"]antagonistic interactions [\/pb_glossary]<\/strong> produce harmful effects. Antagonistic interactions may occur between two antimicrobials or between an antimicrobial and medication used to treat other conditions. For example, antacids taken with antibiotics can delay and reduce the absorption of the antibiotic. Potential harmful effects vary depending on the drugs involved, but antagonistic interactions cause diminished drug activity, decreased therapeutic levels due to elevated metabolism and elimination, or increased potential for toxicity due to decreased metabolism and elimination.\n<div class=\"textbox\">\n<h3 class=\"star\">\u00a0Interactive Activity<\/h3>\n[h5p id=\"7\"]\n\n<sup>\u201cAntimicrobial Knowledge Check\u201d by E. Christman for <a href=\"https:\/\/www.cvtc.edu\/landing-pages\/grants\/open-rn\" target=\"_blank\" rel=\"noopener\">Open RN<\/a> is licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener\">CC BY 4.0<\/a><\/sup>\n\n<\/div>\n&nbsp;","rendered":"<p>The administration of antimicrobial drug therapy involves special considerations to ensure that the therapeutic drug effect is achieved while also maintaining patient safety and minimizing complications.<\/p>\n<p>Let&#8217;s consider variables that impact antimicrobial administration, such as half-life, life span considerations, liver and kidney function, dose dependency\/time dependency, route, and drug interactions.<\/p>\n<h2>Half-Life<\/h2>\n<p><span style=\"text-align: initial;font-size: 1em\">Many antimicrobial medications are administered to ensure a certain therapeutic level of medication remains in the bloodstream, which may require interval or repeated dosing throughout the day. Recall from Chapter 1 that <\/span>half-life is the<span style=\"text-align: initial;font-size: 1em\"> rate at which 50% of a drug is eliminated from the plasma. Half-life can vary significantly among antimicrobial drugs. Some antibiotics, such as penicillin, have a short half-life of only a few hours and must be administered multiple times a day, whereas other antibiotics, such as levofloxacin, have long half-lives and can be administered as a single dose every 24 hours. <\/span><\/p>\n<p><span style=\"text-align: initial;font-size: 1em\">Although a longer half-life can be considered an advantage for a prescribed antibiotic when it comes to convenient dosing intervals, medications with longer half-lives that cause side effects will also exert these side effects over a longer period of time.\u00a0<\/span><\/p>\n<h2>Life Span Considerations<\/h2>\n<p>Many antibiotic dosages are calculated based on the client&#8217;s age and weight. Age and weight are especially important when calculating pediatric dosages, resulting in common medication errors when these calculations are inaccurate. The size and development of the internal organs in infants and children also impact how the body absorbs, distributes, metabolizes, and excretes medications.<\/p>\n<p>In older adults, metabolism of antibiotics by the liver may significantly decline in the older adult. As a result, dosages should be adjusted according to the client\u2019s liver function and their anticipated metabolic rate. First-pass metabolism also decreases with aging, so older adults may have higher \u201cfree\u201d circulating drug concentrations and thus be at higher risk for side effects and toxicities.<\/p>\n<h2>Liver and Kidney Function<\/h2>\n<p>Many antimicrobial medications require tailored dosing based on the client&#8217;s liver and kidney function. For more information about the effects of liver and kidney function on metabolizing and excreting medications, review <a href=\"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/1-5-metabolism\/\" target=\"_blank\" rel=\"noopener\">Chapter 1<\/a>.<\/p>\n<p>Peak and trough blood levels are monitored for some antibiotics to determine how a client&#8217;s body is responding to an antimicrobial. Dosing is then tailored to the individual based on peak and trough levels. This is especially important for older adults or those with known liver and\/or kidney impairment. Individuals with diminished liver and kidney function are prone to developing toxic levels of medications because of their reduced ability to metabolize or clear medications from the body. For more information about peak and trough levels, review the &#8220;<a href=\"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/1-9-efficacy-dose-response-onset-peak-and-duration\/\" target=\"_blank\" rel=\"noopener\">Efficacy, Dose-Response, Onset, Peak, and Duration<\/a>&#8221; section in Chapter 1.<sup><a class=\"footnote\" title=\"This work is a derivative of Microbiology by OpenStax licensed under CC BY 4.0. Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" id=\"return-footnote-92-1\" href=\"#footnote-92-1\" aria-label=\"Footnote 1\"><sup class=\"footnote\">[1]<\/sup><\/a><\/sup><\/p>\n<h2>Dose Dependency\/Time Dependency<\/h2>\n<p>The goal of antimicrobial therapy is to select an optimal dosage that will result in clinical cure, while reducing potential side effects and adverse effects. Many medications are <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_92_507\">dose dependent<\/a><\/strong>, meaning\u00a0there is a more significant killing of the bacteria with increasing levels of the antibiotic. For example, fluroquinolones are dose-dependent medications with higher dosages of antibiotic killing more bacteria.<\/p>\n<p>Other medications are <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_92_508\">time dependent<\/a><\/strong>. Time-dependent medications have optimal bacterial-killing effect at lower doses over a longer period of time. Time-dependent antimicrobials exert their effect by binding to the microorganism for an extensive length of time. Penicillin is an example of a time-dependent medication where duration of the bacteria&#8217;s exposure to the medication has the greatest effect.<sup><a class=\"footnote\" title=\"This work is a derivative of Microbiology by OpenStax licensed under CC BY 4.0. Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" id=\"return-footnote-92-2\" href=\"#footnote-92-2\" aria-label=\"Footnote 2\"><sup class=\"footnote\">[2]<\/sup><\/a><\/sup><\/p>\n<h2>Route<\/h2>\n<p>When administering antimicrobials to clients, nurses must consider the route of drug administration. Many of us may have been prescribed oral antibiotics and have simply filled our prescription and completed the drug therapy within the comfort of our own homes. However, there are many types of infections that do not respond well to oral antimicrobial therapy and require intravenous or intramuscular injections. Clients requiring intravenous or intramuscular injections may require additional considerations regarding hospitalization, home health nursing, or travel to the hospital\/clinic for their therapy. For more information about considerations regarding routes of administration, refer to <a href=\"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/1-3-absorption\/\" target=\"_blank\" rel=\"noopener\">Chapter 1<\/a> on absorption.<\/p>\n<h2>Drug Interactions<\/h2>\n<p>Interactions between drugs may be beneficial or harmful. For example, when treating specific infections, two antibacterial drugs may be administered together to create a greater effect than the efficacy of either medication alone, referred to as <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_92_509\">synergistic interaction <\/a><\/strong>. An example of a synergistic drug combinations is trimethoprim and sulfamethoxazole (Bactrim). Individually, these two drugs provide only bacteriostatic inhibition of bacterial growth, but combined, the drugs are bactericidal.<sup><a class=\"footnote\" title=\"This work is a derivative of Microbiology by OpenStax licensed under CC BY 4.0. Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" id=\"return-footnote-92-3\" href=\"#footnote-92-3\" aria-label=\"Footnote 3\"><sup class=\"footnote\">[3]<\/sup><\/a><\/sup><\/p>\n<p>In contrast to synergistic drug interactions providing a benefit to the client, <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_92_510\">antagonistic interactions <\/a><\/strong> produce harmful effects. Antagonistic interactions may occur between two antimicrobials or between an antimicrobial and medication used to treat other conditions. For example, antacids taken with antibiotics can delay and reduce the absorption of the antibiotic. Potential harmful effects vary depending on the drugs involved, but antagonistic interactions cause diminished drug activity, decreased therapeutic levels due to elevated metabolism and elimination, or increased potential for toxicity due to decreased metabolism and elimination.<\/p>\n<div class=\"textbox\">\n<h3 class=\"star\">\u00a0Interactive Activity<\/h3>\n<div id=\"h5p-7\">\n<div class=\"h5p-iframe-wrapper\"><iframe id=\"h5p-iframe-7\" class=\"h5p-iframe\" data-content-id=\"7\" style=\"height:1px\" src=\"about:blank\" frameBorder=\"0\" scrolling=\"no\" title=\"Module 4: Antimicrobial Basics Knowledge Check\"><\/iframe><\/div>\n<\/div>\n<p><sup>\u201cAntimicrobial Knowledge Check\u201d by E. Christman for <a href=\"https:\/\/www.cvtc.edu\/landing-pages\/grants\/open-rn\" target=\"_blank\" rel=\"noopener\">Open RN<\/a> is licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener\">CC BY 4.0<\/a><\/sup><\/p>\n<\/div>\n<p>&nbsp;<\/p>\n<hr class=\"before-footnotes clear\" \/><div class=\"footnotes\"><ol><li id=\"footnote-92-1\">This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a> <a href=\"#return-footnote-92-1\" class=\"return-footnote\" aria-label=\"Return to footnote 1\">&crarr;<\/a><\/li><li id=\"footnote-92-2\">This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a> <a href=\"#return-footnote-92-2\" class=\"return-footnote\" aria-label=\"Return to footnote 2\">&crarr;<\/a><\/li><li id=\"footnote-92-3\">This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a> <a href=\"#return-footnote-92-3\" class=\"return-footnote\" aria-label=\"Return to footnote 3\">&crarr;<\/a><\/li><\/ol><\/div><div class=\"glossary\"><span class=\"screen-reader-text\" id=\"definition\">definition<\/span><template id=\"term_92_507\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_92_507\"><div tabindex=\"-1\"><p>A more significant response occurs in the body when the medication is administered in large doses to provide a large amount of medication to the site of infection for a short period of time.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_92_508\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_92_508\"><div tabindex=\"-1\"><p>Time dependency occurs when greater therapeutic effects are seen with lower blood levels over a longer period of time.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_92_509\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_92_509\"><div tabindex=\"-1\"><p>Concurrent drug administration producing a synergistic interaction that is better than the efficacy of either drug alone.  An example of synergistic drug combinations is trimethoprim and sulfamethoxazole (Bactrim).<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_92_510\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_92_510\"><div tabindex=\"-1\"><p>Concurrent administration of two drugs causes harmful effects such as a decrease of drug activity, decreased therapeutic levels due to increased metabolism and elimination, or increased potential for toxicity due to decreased metabolism and elimination.  An example of an antagonistic interaction is taking antacids with antibiotics, causing decreased absorption of the antibiotic.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><\/div>","protected":false},"author":83,"menu_order":3,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":""},"chapter-type":[48],"contributor":[],"license":[],"class_list":["post-92","chapter","type-chapter","status-publish","hentry","chapter-type-numberless"],"part":82,"_links":{"self":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/92","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/users\/83"}],"version-history":[{"count":3,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/92\/revisions"}],"predecessor-version":[{"id":781,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/92\/revisions\/781"}],"part":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/82"}],"metadata":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/92\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/media?parent=92"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=92"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/contributor?post=92"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/license?post=92"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}